Frequency Therapeutics Inc expected to post a loss of 67  cents a share - Earnings Preview

Korro Bio

08/08/2022 18:02

* Frequency Therapeutics Inc  FREQ.OQ   FREQ.O  is expected
to show a fall in quarterly revenue when it reports  results on
August 10 (estimated). 
    * ​Refinitiv's mean analyst estimate for Frequency
Therapeutics
Inc is for a loss of 67 cents per share. For the same quarter
last year, the company reported a loss of 52 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and 1 "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Frequency
Therapeutics Inc is $8​, above​ its last closing price of $2.23.
​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Mar. 31 2022  -0.62       -0.63      -0.67     Missed  -5.5
 Dec. 31 2022  0.59        0.15       -0.62     Missed  -506.8
 Sep. 30 2021  -0.52       -0.57      -0.73     Missed  -27.2​
 Jun. 30 2021  -0.51       -0.51      -0.52     Missed  -2.3
 ​​Mar.        -0.28       -0.28      -0.60     Missed  -116.9
 31 2021                                                
 Dec. 31 2020  -0.26       -0.25      -0.30     Missed  -17.8​
 Sep. 30 2020  -0.27       -0.28      -0.16     Beat    42.6
 Jun. 30 2020  -0.19       -0.18      -0.19     Missed  -3.1
 This summary was machine generated August 8 at 17:02 GMT.  All
figures in US dollars  unless otherwise stated